132 related articles for article (PubMed ID: 26104192)
1. Vector-Mediated In Vivo Antibody Expression.
Schnepp BC; Johnson PR
Microbiol Spectr; 2014 Aug; 2(4):AID-0016-2014. PubMed ID: 26104192
[TBL] [Abstract][Full Text] [Related]
2. Vector-mediated antibody gene transfer for infectious diseases.
Schnepp BC; Johnson PR
Adv Exp Med Biol; 2015; 848():149-67. PubMed ID: 25757620
[TBL] [Abstract][Full Text] [Related]
3. Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer.
Lewis AD; Chen R; Montefiori DC; Johnson PR; Clark KR
J Virol; 2002 Sep; 76(17):8769-75. PubMed ID: 12163597
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus delivery of broadly neutralizing antibodies.
Schnepp BC; Johnson PR
Curr Opin HIV AIDS; 2014 May; 9(3):250-6. PubMed ID: 24638019
[TBL] [Abstract][Full Text] [Related]
5. Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys.
Johnson PR; Schnepp BC; Zhang J; Connell MJ; Greene SM; Yuste E; Desrosiers RC; Clark KR
Nat Med; 2009 Aug; 15(8):901-6. PubMed ID: 19448633
[TBL] [Abstract][Full Text] [Related]
6. Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.
Andersson AC; Ragonnaud E; Seaton KE; Sawant S; Folgori A; Colloca S; Labranche C; Montefiori DC; Tomaras GD; Holst PJ
Vaccine; 2016 Oct; 34(44):5344-5351. PubMed ID: 27633665
[TBL] [Abstract][Full Text] [Related]
7. Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection.
Saunders KO; Wang L; Joyce MG; Yang ZY; Balazs AB; Cheng C; Ko SY; Kong WP; Rudicell RS; Georgiev IS; Duan L; Foulds KE; Donaldson M; Xu L; Schmidt SD; Todd JP; Baltimore D; Roederer M; Haase AT; Kwong PD; Rao SS; Mascola JR; Nabel GJ
J Virol; 2015 Aug; 89(16):8334-45. PubMed ID: 26041300
[TBL] [Abstract][Full Text] [Related]
8. Antibody-based protection against HIV infection by vectored immunoprophylaxis.
Balazs AB; Chen J; Hong CM; Rao DS; Yang L; Baltimore D
Nature; 2011 Nov; 481(7379):81-4. PubMed ID: 22139420
[TBL] [Abstract][Full Text] [Related]
9. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
[TBL] [Abstract][Full Text] [Related]
10. Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention.
Brady JM; Baltimore D; Balazs AB
Immunol Rev; 2017 Jan; 275(1):324-333. PubMed ID: 28133808
[TBL] [Abstract][Full Text] [Related]
11. Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo.
Rudicell RS; Kwon YD; Ko SY; Pegu A; Louder MK; Georgiev IS; Wu X; Zhu J; Boyington JC; Chen X; Shi W; Yang ZY; Doria-Rose NA; McKee K; O'Dell S; Schmidt SD; Chuang GY; Druz A; Soto C; Yang Y; Zhang B; Zhou T; Todd JP; Lloyd KE; Eudailey J; Roberts KE; Donald BR; Bailer RT; Ledgerwood J; ; Mullikin JC; Shapiro L; Koup RA; Graham BS; Nason MC; Connors M; Haynes BF; Rao SS; Roederer M; Kwong PD; Mascola JR; Nabel GJ
J Virol; 2014 Nov; 88(21):12669-82. PubMed ID: 25142607
[TBL] [Abstract][Full Text] [Related]
12. Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.
Kilgore KM; Murphy MK; Burton SL; Wetzel KS; Smith SA; Xiao P; Reddy S; Francella N; Sodora DL; Silvestri G; Cole KS; Villinger F; Robinson JE; Pulendran B; Hunter E; Collman RG; Amara RR; Derdeyn CA
J Virol; 2015 Aug; 89(16):8130-51. PubMed ID: 26018167
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins.
Mascola JR; Sambor A; Beaudry K; Santra S; Welcher B; Louder MK; Vancott TC; Huang Y; Chakrabarti BK; Kong WP; Yang ZY; Xu L; Montefiori DC; Nabel GJ; Letvin NL
J Virol; 2005 Jan; 79(2):771-9. PubMed ID: 15613305
[TBL] [Abstract][Full Text] [Related]
14. Expression of HIV-1 broadly neutralizing antibodies mediated by recombinant adeno-associated virus 8 in vitro and in vivo.
Yu Y; Fu L; Jiang X; Guan S; Kuai Z; Kong W; Shi Y; Shan Y
Mol Immunol; 2016 Dec; 80():68-77. PubMed ID: 27835755
[TBL] [Abstract][Full Text] [Related]
15. Expression of Human Immunodeficiency Virus Type 1 Neutralizing Antibody Fragments Using Human Vaginal Lactobacillus.
Marcobal A; Liu X; Zhang W; Dimitrov AS; Jia L; Lee PP; Fouts TR; Parks TP; Lagenaur LA
AIDS Res Hum Retroviruses; 2016; 32(10-11):964-971. PubMed ID: 26950606
[TBL] [Abstract][Full Text] [Related]
16. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a self-inactivating lentiviral vector expressing simian immunodeficiency virus gag for induction of specific immune responses in vitro and in vivo.
Buffa V; Negri DR; Leone P; Borghi M; Bona R; Michelini Z; Compagnoni D; Sgadari C; Ensoli B; Cara A
Viral Immunol; 2006; 19(4):690-701. PubMed ID: 17201664
[TBL] [Abstract][Full Text] [Related]
18. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.
Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X
J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234
[TBL] [Abstract][Full Text] [Related]
19. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
Iseda S; Takahashi N; Poplimont H; Nomura T; Seki S; Nakane T; Nakamura M; Shi S; Ishii H; Furukawa S; Harada S; Naruse TK; Kimura A; Matano T; Yamamoto H
J Virol; 2016 Jul; 90(14):6276-6290. PubMed ID: 27122584
[TBL] [Abstract][Full Text] [Related]
20. A constant threat for HIV: Fc-engineering to enhance broadly neutralizing antibody activity for immunotherapy of the acquired immunodeficiency syndrome.
Nimmerjahn F
Eur J Immunol; 2015 Aug; 45(8):2183-90. PubMed ID: 26140474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
